Active-ingredient Dossier
Ciclosporin
Active-ingredient Dossier for Ciclosporin (immunosuppressant agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: CEQUA
- Brand: IKERVIS
- Brand: NEORAL
- Brand: SANDIMMUN
- Brand: Vevye
- Brand: APO-CICLOSPORIN
- Therapeutic area: Immunology
- Therapeutic area: Ophthalmology
What is
Ciclosporin Ciclosporin is an immunosuppressant agent.
Australian brands containing
Ciclosporin — CEQUA — IKERVIS — NEORAL — SANDIMMUN — APO-CICLOSPORIN — CICLOSPORIN-WGR — Vevye
Therapeutic areas
Ciclosporin is registered in immunology (11 brands) and ophthalmology (4 brands).
Sponsor landscape
The ingredient is marketed by Arrotex Pharmaceuticals, Strides Pharma Science, Novartis Pharmaceuticals, Sun Pharma, GM Pharma, and Seqirus.
PBS and regulatory activity
Four brands containing ciclosporin have PBS-listed items, with the latest PBS schedule date being 1 May 2026. The latest PBAC outcome was recorded on 1 March 2022, and the latest AusPAR was published on 3 December 2020.